Scientific review & publication

Sources and independent review

Formal scientific approval requires cited sources, version tracking and independent human review. English and Spanish are reviewed separately. Citation and factual verification are distinct from clinical interpretation. Board appointments and reviewer assignment remain pending; no completed comprehensive review is claimed.

AI assistance and corrections

AI may assist draft preparation; humans remain responsible for checking sources, language and interpretation. AI drafts do not receive automatic scientific approval. Scientific edits and citation changes invalidate existing review in the CMS and require renewed review. The deliberate public review release is frozen, not an automatic projection of private drafts.

Editorial boundaries and evidence

Editorial working policy — scientific and legal review pending. Proposed practices, not completed assessments or a staffed community reporting service.

PEPTIDE Americas provides educational information about peptides, scientific research and reported community experiences. We do not recommend individual treatments, prescribe products, or diagnose, treat, cure or prevent disease. Our content is not a substitute for advice from a qualified healthcare professional. Inclusion of a compound or external resource does not constitute endorsement.

Research findings and reported experiences are presented separately. A community report does not establish safety, effectiveness or causation. Findings about one preparation, route, population or outcome should not be assumed to apply to another.

Labels apply to individual claims: molecule, formulation, route, population and endpoint. Study setting and methodological confidence are separate. Stronger human evidence requires qualified review of relevant study quality, consistency and limitations, never publication counts. Preliminary or mixed findings require explicit limitations. Identify animal or laboratory models; cultured human cells are not a human treatment trial. Opinion requires attributed basis and interests. Insufficient evidence requires a documented assessment; unassessed means no completed assessment, not safe or ineffective. Preserve negative findings. These proposed categories are not a validated grading system such as GRADE.

Regulatory status is separate: jurisdiction, exact product, indication, formulation, official source, date checked and reviewer. Availability, compounding, advisory votes or a similar name do not establish approval. Topic biology is not approval of every therapy discussed.

Separate primary research, further reading and commercial/community commentary. Use original summaries and direct links, not copied images, tables, paid-course passages or translated articles without required rights. Attribution is not permission; no fixed quotation length guarantees fair use. Record applicable permissions. Disclose actual material relationships near links; unknown does not mean independent or partner. No buying links, discounts, protocol selectors or endorsement badges. FTC and copyright guidance inform review, not a compliance certificate or legal advice.

Community report — unverified: an attributed experience, not evidence of causation, safety or effectiveness. Require traceable public source or publication consent, date, attributed summary and interests; do not expose identifiers or private posts. Preserve adverse, neutral and mixed experiences without estimating prevalence from selected posts. No reported harm is not demonstrated safety. Submissions and moderation remain proposals; the contact inbox is inactive.

Proposed claim-level labels

• Human research — stronger evidence
• Human research — preliminary or mixed
• Animal or laboratory research
• Clinical experience or expert opinion
• Community report — unverified
• Insufficient evidence for this claim
• Not yet assessed